» Articles » PMID: 19104810

Towards Quantitative PET/MRI: a Review of MR-based Attenuation Correction Techniques

Overview
Date 2008 Dec 24
PMID 19104810
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Positron emission tomography (PET) is a fully quantitative technology for imaging metabolic pathways and dynamic processes in vivo. Attenuation correction of raw PET data is a prerequisite for quantification and is typically based on separate transmission measurements. In PET/CT attenuation correction, however, is performed routinely based on the available CT transmission data.

Objective: Recently, combined PET/magnetic resonance (MR) has been proposed as a viable alternative to PET/CT. Current concepts of PET/MRI do not include CT-like transmission sources and, therefore, alternative methods of PET attenuation correction must be found. This article reviews existing approaches to MR-based attenuation correction (MR-AC). Most groups have proposed MR-AC algorithms for brain PET studies and more recently also for torso PET/MR imaging. Most MR-AC strategies require the use of complementary MR and transmission images, or morphology templates generated from transmission images. We review and discuss these algorithms and point out challenges for using MR-AC in clinical routine.

Discussion: MR-AC is work-in-progress with potentially promising results from a template-based approach applicable to both brain and torso imaging. While efforts are ongoing in making clinically viable MR-AC fully automatic, further studies are required to realize the potential benefits of MR-based motion compensation and partial volume correction of the PET data.

Citing Articles

Correlations Between MR Apparent Diffusion Coefficients and PET Standard Uptake Values in Simultaneous MR-PET Imaging of Prostate Cancer.

Pozaruk A, Atamaniuk V, Pawar K, Carey A, Cheng J, Cholewa M Int J Mol Sci. 2025; 26(3).

PMID: 39940674 PMC: 11817574. DOI: 10.3390/ijms26030905.


Machine Learning in PET: from Photon Detection to Quantitative Image Reconstruction.

Gong K, Eric Berg , Cherry S, Qi J Proc IEEE Inst Electr Electron Eng. 2023; 108(1):51-68.

PMID: 38045770 PMC: 10691821. DOI: 10.1109/JPROC.2019.2936809.


Imaging of Angiogenesis in White Matter Hyperintensities.

Ding L, Hou B, Zang J, Su T, Feng F, Zhu Z J Am Heart Assoc. 2023; 12(21):e028569.

PMID: 37889177 PMC: 10727415. DOI: 10.1161/JAHA.122.028569.


A review of PET attenuation correction methods for PET-MR.

Krokos G, MacKewn J, Dunn J, Marsden P EJNMMI Phys. 2023; 10(1):52.

PMID: 37695384 PMC: 10495310. DOI: 10.1186/s40658-023-00569-0.


In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.

Csikos C, Vagner A, Nagy G, Kalman-Szabo I, Szabo J, Ngo M Diagnostics (Basel). 2023; 13(2).

PMID: 36673046 PMC: 9858384. DOI: 10.3390/diagnostics13020236.


References
1.
Ponisch F, Richter C, Just U, Enghardt W . Attenuation correction of four dimensional (4D) PET using phase-correlated 4D-computed tomography. Phys Med Biol. 2008; 53(13):N259-68. DOI: 10.1088/0031-9155/53/13/N03. View

2.
Kinahan P, Townsend D, Beyer T, SASHIN D . Attenuation correction for a combined 3D PET/CT scanner. Med Phys. 1998; 25(10):2046-53. DOI: 10.1118/1.598392. View

3.
Meltzer C, Kinahan P, Greer P, Nichols T, Comtat C, Cantwell M . Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med. 2000; 40(12):2053-65. View

4.
Tsukamoto E, Ochi S . PET/CT today: system and its impact on cancer diagnosis. Ann Nucl Med. 2006; 20(4):255-67. DOI: 10.1007/BF02984642. View

5.
Czernin J, Allen-Auerbach M, Schelbert H . Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007; 48 Suppl 1:78S-88S. View